PBLD: Immune Checkpoint Inhibitors - Implications in Perioperative Patient Care
Learning objectives:
After participating in this session, participants will be able to:
- Recognize the patient population who may be on immune checkpoint inhibitors
- Distinguish the immune-mediated adverse events (irAEs) that may be associated with these agents
- Develop a plan for the perioperative management of patients on immune checkpoint inhibitors and how to manage potential perioperative complications surrounding these agents
- Recognizing what the immune checkpoint mediators are and what is used most commonly